PCSK9 Inhibitors as Adjunctive Therapies in Hypercholesterolemia: Benefits, Limitations, and Possible Alternatives

Hamad, M; Muhammad, JS; Rah, B; Hasan, H; Taneera, J; Soofi, A; Awadallah, S

Hamad, M (通讯作者),Univ Sharjah, Res Inst Med & Hlth Sci, Sharjah 27272, U Arab Emirates.;Hamad, M (通讯作者),Univ Sharjah, Dept Med Lab Sci, Sharjah 27272, U Arab Emirates.

ADVANCED THERAPEUTICS, 2023; ():

Abstract

The clinical application of statins as anti-hypercholesterolemia medications, while very beneficial, remains limited by intolerance and side effects. ......

Full Text Link